ESC 365 - Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome

HFA Premium Access

Combined therapy with rosuvastatin and ezetimibe on inflammatory state and pro-inflammatory cytokines in patients with coronary heart disease and metabolic syndrome

Session: Poster Session 1 - Risk factors and prevention

Topic: Diabetes and the Heart

Speaker: Doctor J. Uzokov (Tashkent, UZ)

Event: Heart Failure 2019

Congress Presentation

Add to my library

About the speaker

Doctor Jamol Uzokov

Republican Specialized Scientific-Practical Medical Center Therapy and Medical Rehabilitation, Tashkent (Uzbekistan)

2 followers

11 more presentations in this session

Asian Diabetes Outcome Prevention Trial (ADOPT)

Speaker: Doctor C. Chandramouli (Singapore, SG)

Nesfatin-1 activity in hypertensive obese patients changes with the duration of hypertension

Speaker: Associate Professor M. Vizir (Kharkiv, UA)

Anthropometric measurements of central adiposity are superior predictors of heart failure in the general population - data of PREVEND

Speaker: Doctor N. Suthahar (Rotterdam, NL)

Diabetes mellitus is a predictor of development of heart failure independent of HTN, CAD and diastolic function: a population based study

Speaker: Professor H. Chen (Rochester, US)

The receptor for advanced glycation end products and its ligands modulate cardiovascular cell apoptosis in diabetic patients

Speaker: Doctor J. Tsoporis (Toronto, CA)

Access the full session

Poster Session 1 - Risk factors and prevention

Speakers: Doctor J. Uzokov, Doctor C. Chandramouli, Associate Professor M. Vizir, Doctor N. Suthahar, Professor H. Chen...

About the event

Heart Failure 2019

25 May - 28 May 2019

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources